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SUMMARY Scleredema adultorum or Buschke’s scleredema is 
a rare disorder that belongs to the group of mucinoses. Diffuse, 
sudden swelling, hardening and induration of the skin can 
occur in children and younger women as well as in older men. 
The dermis is thickened because of the increased collagen 
glycosylation, like that in diabetic stiff skin syndrome. The face 
is most often involved. In older persons the trunk is usually 
ﬁrst involved. There is relative sparing of the extremities, with 
no distal or Raynaud’s phenomenon. Eosinophilic fasciitis, 
scleromyxedema, associated gammopathy, and other forms of 
edema and mucin deposition must be excluded on differential 
diagnosis. Antibiotics, sometimes high doses of intravenous 
penicillin, systemic corticosteroids, systemic PUVA and PUVA 
bath therapy seem most promising for the management of the 
disorder. Our patients were aged 27, 60, 64, 69 and 72 years, 
with typical skin lesions, thus that term “adultorum” does not 
appear to ﬁt well. 
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INTRODUCTION
 This article about the rare skin disorder of 
Buschke’s scleredema is dedicated to the 63rd an-
niversary of the death of great Jewish dermatolo-
gist.
 Scleredema adultorum or Buschke’s sclerede-
ma is a rare disorder that belongs to the group of 
mucinoses, and is characterized by diffuse non-
pitting swelling and induration of the skin. Skin 
biopsies reveal marked thickening of the dermis 
due to collagenous replacement of the subcutis 
and deposition of hyaluronic acid between the 
collagen ﬁbers. The disease classically affects 
exclusively the skin. However, in 1998, Umler et 
al. have reported on Buschke’s scleredema with 
a wide variety of extracutaneous manifestations 
on the tongue, pharynx and upper esophagus (1). 
Eponymously, many other scleredema-like dis-
eases have been recognized since Buschke dis-
covered this disease in 1902. 
Scleredema and concomitant Diseases
 Buschke-Ollendorff syndrome and nail-patella 
syndrome are rare connective tissue disorders in-
herited in an autosomal dominant pattern, charac-
terized by cutaneous and bone lesions. Drouin and 
Grenon were the ﬁrst to describe this disorder in a 
3-year-old boy (2). This association had not been 
reported previously, suggesting that these two 
147
Acta Dermatovenerol Croat                2005;13(3):147-152  HISTORY OF MEDICINE
connective tissue disorders may share the same 
gene location with different mutations or involve 
different mutated genes that share downstream 
segments of their signaling pathways. Chronic id-
iopathic neutropenia was also observed (2).
 Buschke-Löwenstein tumor (BLT, giant condy-
loma) is a rare disease that arises on male and 
female external genitalia. BLT arises from the con-
ﬂuence of multiple condylomata acuminata and 
is induced by human papillomavirus (HPV) infec-
tion. BLT presents a clinical malignancy, yet it is 
known to be a histologically benign tumor, even if 
it carries a risk of malignant transformation (3,4). 
The role of HPV as a cofactor involved in carcino-
matous transformation remains controversial (3). 
Some authors consider these tumors to be benign 
tumors or giant condylomata (non-metastatic, as-
sociated with HPV 6-11), while others consider 
them to be borderline malignant associated with 
oncogenic virus (HPV 16 and 18). This evolution 
follows the alteration by a viral protein of the func-
tions of the tumor suppressor protein P53 (3). The 
surgery remains the reference treatment although 
there is a possibility of frequent recurrences. Ra-
diotherapy and chemotherapy have been sug-
gested as adjuvant treatments for complicated 
forms. It is advisable to treat it early. The treatment 
by combined CO2 laser surgery excision-vaporiza-
tion, with long-term follow-up has been described 
by Frega et al. (4).
 Scleroderma-like disorders are widely disparate 
conditions mimicking either systemic sclerosis or 
cutaneous localized scleroderma, not infrequent-
ly displaying features of both. The recognition of 
scleroderma-like disorders is of practical impor-
tance because by establishing the cause of the 
disease, it is possible to introduce an effective 
therapy, as in scleredema Buschke or scleredema 
diabetoricum, sclerodermiform porphyria, Borrelia 
burgdorferi-induced sclerodermiform acrodermati-
tis atrophicans, sclerodermiform phenylketonuria, 
drug-induced conditions, etc. (5). Scleroderma-like 
disorders suggest that the pathogenesis of skin 
sclerosis and internal evolvement may be diver-
gent, and of various causes. Some of them such as 
atrophoderma Pasini-Pierini or progressive facial 
hemiatrophy frequently overlapping with sclero-
derma make the differentiation very difﬁcult, and 
the diagnosis is often arbitrary. Some, as sclero-
dermiform graft-versus-host-reaction, point to the 
autoimmune origin of scleroderma. The congenital 
sclerodermiform conditions present a large spec-
trum of still not widely known and extremely het-
erogeneous syndromes, associated with numer-
ous anomalies and/or malignancies (5).
 The ﬁrst report of scleredema and the second 
of reticular erythematous mucinosis in three dif-
ferent HIV-infected patients seem to be more than 
coincidental (6).
 Valente et al. reported on the association be-
tween acanthosis nigricans and scleredema in 
1997. There are three clinical types of scleredema. 
The ﬁrst is preceded by an upper airway infection 
and progresses rapidly before regressing sponta-
neously within a few months. The second type is 
associated with chronic diabetes. The third type is 
associated with monoclonal gammopathy, rarely of 
myelomatous type, and develops insidiously (7). A 
56-year-old woman developed scleredema when 
acanthosis nigricans appeared together with IgA 
kappa multiple myeloma. Therapy with melpha-
lan and prednisolone for myeloma proved effec-
tive also for scleredema and acanthosis nigricans 
(7). Only ﬁve cases of associated scleredema and 
multiple myeloma have been reported, four with 
kappa IgG myeloma and only one with IgA myelo-
ma (7). An association with acanthosis nigricans 
and scleredema could be coincidental although 
the fact that the different manifestations regressed 
together after the myeloma treatment would sug-
gest some relationship between these three dis-
eases (7). Although scleredema of Buschke is a 
rare disorder that usually resolves spontaneously, 
Sansom et al. (1994) describe a fatal case of ex-
tensive skin changes and IgA myeloma in a 60-
year-old woman who did not respond to conven-
tional myeloma therapy and died from sequels of 
the progressive skin disease (8). 
 In 2000, Grudeva-Popova and Dobrev reported 
on Buschke’s scleredema associated with multi-
ple myeloma and IgG kappa monoclonal hyper-
gammaglobulinemia. The bioengineering method 
proved useful for early detection and monitoring 
of skin involvement in the patient with this disease 
association (9). Systemic involvement in sclerede-
ma of Buschke associated with IgG-kappa para-
proteinemia was ﬁrst described in a 60-year-old 
man with scleredema and evidence of mucin de-
position on biopsies from multiple extracutaneous 
sites (10).
 Scleredema adultorum of Buschke as an un-
usual manifestation of diabetes mellitus that can 
result in painful indurations and thickening of the 
skin with associated limitation of motion, has been 
previously reported to be responsive to radio-
therapy. Several patients were treated by photon 
ﬁelds and multiple electron ﬁelds encompassing 
the entire neck, arms and thorax, as reported by 
Tobler et al. (2000) (11).
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 Banney et al. (2000) report on a case of scler-
edema diabeticorum of Buschke associated with 
nuchal ﬁbroma and organic solvent exposure. 
This is the ﬁrst report on the association of these 
conditions, with increased and thickened collagen 
bundles without signiﬁcant ﬁbroblast proliferation 
in a patient with insulin-dependent diabetes melli-
tus with complications of retinal vessel thrombosis 
and peripheral neuropathy (12).
 Stiff-man syndrome is a rare disorder of the 
central nervous system characterized by muscu-
lar rigidity and superimposed spasms. Happe et 
al. (1999) report on a 22-year-old male patient 
with stiff-man syndrome. He developed painful ri-
gidity of the trunk, starting in the neck. Massive 
stiffness of the trunk with pale appearance of the 
skin and initial stage of swallowing and respiration 
impairment were observed. Skin biopsy presented 
typical characteristics of  scleredema adultorum, a 
rare connective tissue disorder of unknown etiolo-
gy. Scleredema adultorum should be regarded as 
a differential diagnosis of the stiff-man syndrome 
(13). In 1996, a 73-year-old retired truck driver was 
diagnosed with acute pericarditis, which respond-
ed well to steroid treatment. In January 1997, he 
noted a swelling of the abdominal skin, genitalia 
and limbs, sparing the feet. Echocardiography was 
consistent with inﬁltrative cardiomyopathy, and af-
ter his cardiac condition had suddenly worsened, 
he suffered a cardiac arrest and died. Autopsy 
ﬁndings revealed systemic scleredema adultorum 
of Buschke. Amyloid deposits were also found. 
There was a coexistence of systemic Buschke’s 
scleredema with inﬁltrative cardiomyopathy, IgG 
kappa gammopathy and amyloidosis (14).
 Ulmer et al. (1998) have noted 24 cases of as-
sociated monoclonal gammopathy in the literature. 
They describe a 75-year-old patient with a 19-year 
history of scleredema adultorum with monoclo-
nal gammopathy and involvement of the tongue, 
pharynx and upper esophagus. Furthermore, 
polyneuropathy, ocular involvement with restricted 
eye movements and sicca syndrome were pres-
ent. The simultaneous occurrence of cutaneous 
scleredema with any one of the above mentioned 
manifestations has been reported before. The 
wide variety of extracutaneous manifestations of 
scleredema as found in this patient has not been 
previously described (1).
 Tate et al. (1996) describe seven adults with 
scleredema and diabetes mellitus for an aver-
age of 13 years prior to the onset of scleredema. 
They had complications of diabetes, especially 
retinopathy, neuropathy and peripheral vascular 
disease. Scleredema did not resolve on therapy in 
any of these patients (15). In all of them histopa-
thology revealed thickened dermal collagen with 
a mild inﬁltrate of mucin in deeper dermis. In case 
of one scleredema patient with insulin dependent 
diabetes without vascular complications, electron 
microscopy demonstrated heterogeneity in size 
and density of collagen ﬁbrils and presence of ﬁla-
mentous material between them (16).
 Scleredema adultorum or Buschke’s sclerede-
ma belongs to the group of mucinoses. There are 
reports on many associations with scleredema 
adultorum, e.g., with diabetes mellitus and mul-
tiple myeloma. Jacob et al. (2002) have reported 
on a case of scleredema adultorum and second-
ary hyperparathyroidism in a 46-year-old patient. 
The increased levels of parathormone could have 
inﬂuenced the collagen metabolism (17). Koga 
(2001) described a 59-year-old woman with se-
vere diabetic scleredema associated with hetero-
zygous familial hypercholesterolemia treated with 
low-density lipoprotein apheresis therapy monthly 
or every 2 weeks in addition to drugs to lower se-
rum lipids for hypercholesterolemia. Scleredema 
had not improved but after 3 years of treatment 
for hyperlipidemia the authors demonstrated his-
topathologic improvement in the dermis of cervical 
skin. They have concluded that weekly low-densi-
ty lipoprotein apheresis therapy is effective for dia-
betic scleredema that is resistant to conventional 
treatments (18). Parmar et al. reported on a rarity 
of scleredema adultorum developing in an 8-year-
old male child after chickenpox. The patient had a 
benign course and spontaneous recovery in two 
weeks (19). This was the ﬁrst case of scleredema 
adultorum development after chickenpox. A 6-
year-old female patient presented with a rapidly 
progressive scleredema-like syndrome involving 
almost the entire integument. Initially clinical pat-
tern and histopathologic data of both eosinophilic 
fasciitis and scleredema adultorum were present. 
The authors concluded that eosinophilic fasciitis 
and scleredema adultorum might be subtypes of 
one disease entity (20).
 Mechanical properties of the skin in a patient 
with scleredema of Buschke were investigated by 
Dobrev (1998) by a noninvasive in vivo method 
using a suction device. He made clinical scoring 
of the indurated skin, and measured skin elasticity 
and distensibility. Low values of skin distensibility 
correlated with a severe skin induration. The meth-
od applied can be used for objective and quantita-
tive assessment of skin involvement in scleroder-
ma of Buschke (21). A signiﬁcant clinical improve-
149ACTA DERMATOVENEROLOGICA CROATICA
Lipozenčić et al.:   Acta Dermatovenerol Croat
Buschke’s scleredema and concomitant diseases 2005;13(3):147-152
ment was obtained with electron-beam therapy in 
a case of scleredema adultorum associated with 
IgA kappa monoclonal hypergammaglobulinemia 
(22). Scleredema seems to be linked to monoclo-
nal hypergammaglobulinemia, but the relationship 
between the skin disorder and the immunoglobu-
lin abnormality remains to be elucidated (22). A 
case of scleredema and smoldering myeloma has 
been reported by Schmidt et al. (1992) in a 46-
year-old male Caucasian who subsequently had 
classic ﬁndings of scleredema, monoclonal immu-
noglobulin G lambda light chain in serum. Find-
ings in a bone marrow biopsy specimen revealed 
an increased percentage of plasma cells, some of 
which were atypical (23). The success of extra-
corporeal photopheresis in a scleredema patient 
with paraproteinemia was described by Stables et 
al. in 2000 (24). In three patients clinical evolution 
of skin induration, thickness, and ultrasonography 
were evaluated at baseline and after PUVA-bath 
treatment (median - 59 expositions and a cumula-
tive UVA dose of 245.7 J/cm2). Ultrasonography 
showed a signiﬁcant reduction in both skin thick-
ness and density. Hager et al. (1998) concluded 
that PUVA-bath therapy appears to be effective in 
the treatment of scleredema adultorum (25). Bow-
en et al. treated scleredema adultorum of Buschke 
with radiation therapy. Radiotherapy appears to 
be a viable therapeutic option in extreme cases 
of this difﬁcult-to-treat disease (26). Konemann et 
al. proved that ionizing radiation is important, ef-
fective and well-tolerated therapy in the treatment 
of severe cases and may be a candidate ﬁrst-line 
treatment of this disease (27). Eberlein-Konig et 
al. reported on scleredema adultorum showing 
striking clinical improvement to medium-dose 
UVA1 phototherapy (single dose-50 J/cm2; 35 ex-
positions) (28).
 Scleredema in children under 15 years of age 
was rare in Japan before 1996. A total of 166 
cases of the disease were reported (29). A 3-year-
old Japanese girl had had a bacterial infection of 
the tonsils three weeks before the skin lesions 
appeared, with induration of the skin of the face, 
shoulders, extensor aspect of the arms and proxi-
mal part of the forearms. Skin lesions expanded 
from the middle part of the forearms and gradually 
disappeared (29). Corn and Swetter (1994) report-
ed on a case of 8-year-old boy with coincidental 
streptococcal colonization and relatively benign 
presentation of the disease, and the characteristic 
mucopolysaccharide intradermal staining of skin 
biopsy (30). 
 Buschke alone or in collaboration with his assis-
tants has published numerous papers on various 
dermatological problems. Many of these papers 
dealt with the signiﬁcance of the skin for immunity 
in syphilis (in 1929 with A. Joseph and B. Peiser), 
and the inﬂuence of arsphenamine on this immu-
nity. Another entities were keratoderma maculosa 
disseminata symmetrica (in 1910, with H. Fischer) 
and dermatoﬁbrosis cuticularis disseminata (in 
1928, with Helen Ollendorff) (28).
REPORT ON FIVE CASES 
 The scleredema of Buschke (scleredema adul-
torum) (1900) was one of the dermatologic entities 
discovered by Abraham Buschke (1868-1943). 
 Between 1997 and 2003 only ﬁve cases of 
scleredema have been diagnosed out of the to-
tal 7648 of patients with scleredema consulted in 
our Department. Circumscribed scleroderma and 
progressive scleroderma have been diagnosed 
much more often (n=93 and n=33 respectively) 
(Table 1.). All our patients presented diffuse swell-
ing and induration of the skin just like in case of 
scleredema described by Buschke in 1900. In all 
cases sudden hardening of the skin in the cervi-
cothoracic region with extension to the trunk and 
proximal upper limbs were recorded (Fig. 1.). His-
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1 1997 27 M Yes
1588
23 6 2 2
2 1997 64 M Yes 4
3 1998 72 F Yes 1494 11 3 2 0 4
4 1999 60 F Yes 1295 15 5 0 1 2
5 2000 69 F Yes 1097 15 9 1 1 0
2001 0 0 0 1101 17 6 2 1 0
2002 0 0 0 1073 12 4 1 1 0
Total number of hospitalized patients 7648
Table 1. Number of patients with Buschke’s scleredema hospitalized at University Department of 
Dermatology and Venereology, Zagreb University Hospital Center, Zagreb, Croatia, 1997-2002
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tologically, skin biopsies revealed thickening of the 
dermis due to collagenous replacement because 
of increased collagen glycosylation. None of the 
patients had association with some other, extra-
cutaneous disease. Only one middle-aged patient 
had insulin dependent diabetes mellitus without 
clinically relevant complications. The onset was 
subtle and the involvement persistent. The patients 
were aged from 27 to 74 years. There was relative 
sparing of the extremities and no Raynaud’s phe-
nomenon. Erythema and induration of the poste-
rior neck and the back were commonly observed. 
None of the patients had systemic manifestations 
(serositis, dysarthria, dysphagia, myositis, etc.). 
The patients were treated with penicillin (n=3), 
PUVA-bath therapy  (n=4), and one with oral cor-
ticosteroids. However, aggressive therapies were 
not introduced because the cases were not asso-
ciated with myeloma or systemic disabling mani-
festations.
CONCLUSION 
 Although Buschke has been credited with the 
ﬁrst description of scleredema, Pitford’s descrip-
tion dates from 1867. Scleredema is an unusual 
disease that affects all races. A relationship with 
diabetes mellitus was established in 1970 (32), 
and is considered to be a pathogenetic factor. 
During six years we have only ﬁve patients with 
scleredema. Abraham Buschke was an outstand-
ing dermatologist and researcher who contributed 
signiﬁcantly to the development of clinical and sci-
entiﬁc dermatology. As Dr. A. Hollander wrote 20 
years ago: “History happens; it records creation 
and destruction, generation and degeneration, 
joy and sorrow. Its facts can be recalled as les-
sons, but its events cannot be recalled to change” 
(33,34). Nothing could be more appropriate here.
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